Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ideal AER, Internet Legislation Outlined By CFSAN’s Brackett, FTC’s Peeler

This article was originally published in The Tan Sheet

Executive Summary

Legislation for dietary supplement AERs should take into account that FDA needs detailed ingredient information in the reports to establish causality, according to Center for Food Safety & Applied Nutrition Director Robert Brackett, PhD
Advertisement

Related Content

SAFE WEB Act signed
SAFE WEB Act signed
SAFE WEB Act signed
AERs To Go Online: Drug Safety Budget Proposal Funds Web Version
AERs To Go Online: Drug Safety Budget Proposal Funds Web Version
Prop 65 Steroid Suit Planned Against Supplements Named In Post
Trade Groups To Rep. Davis: FDA Should Pull Steroids Sold As Supplements

Topics

Advertisement
UsernamePublicRestriction

Register

PS099176

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel